CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus, Inc. (NASDAQ: ZLCS) a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced that Mark Corrigan, President and CEO is scheduled to present at the Fifth Annual JMP Securities Healthcare Conference at 9:30am EDT on September 27, 2010, at the New York Palace Hotel. Interested parties may access a live webcast of the presentation by visiting the Zalicus website at www.zalicus.com or through the provider’s website http://www.wsw.com/webcast/jmp11/zlcs/. The webcast will be archived on the Zalicus website following the event.
